Home
>
National Drug Code (NDC)
>
Tranexamic Acid
Tranexamic Acid - 60505-3638-3 - (Tranexamic Acid)
Drug Information of Tranexamic Acid
| Product NDC: | 60505-3638 |
| Proprietary Name: | Tranexamic Acid |
| Non Proprietary Name: | Tranexamic Acid |
| Active Ingredient(s): | 650 1/1 & nbsp; Tranexamic Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tranexamic Acid
| Product NDC: | 60505-3638 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202286 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121114 |
Package Information of Tranexamic Acid
| Package NDC: | 60505-3638-3 |
| Package Description: | 30 TABLET in 1 BOTTLE (60505-3638-3) |
NDC Information of Tranexamic Acid
| NDC Code | 60505-3638-3 |
| Proprietary Name | Tranexamic Acid |
| Package Description | 30 TABLET in 1 BOTTLE (60505-3638-3) |
| Product NDC | 60505-3638 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tranexamic Acid |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121114 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | TRANEXAMIC ACID |
| Strength Number | 650 |
| Strength Unit | 1/1 |
| Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
